Skip to main content
CTRE logo

CTRE · CareTrust REIT, Inc. · Financials

Track CTRE — free
$36.45 +0.61 (+1.70%) At close · Oct 20
Market Cap
$8.61B
Shares
236.29M
Volume · Oct 20 1.67M Avg daily vol (3M) 2.31M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$476.39M +60.8%
FY2025 Revenue FY2012–FY2025
Net Income
$320.54M +156.3%
FY2025 Net Income FY2012–FY2025
Gross Margin
100% +1pp
FY2021 Gross Margin FY2016–FY2021
Diluted EPS
$1.57 +96.2%
FY2025 Diluted EPS FY2012–FY2025
Operating Cash Flow
$394.03M +61.3%
FY2025 Operating Cash Flow FY2012–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
$571.43M $476.39M $296.29M $217.77M $196.13M $192.35M $178.33M $163.4M $156.94M $132.98M $104.68M $74.95M $58.9M $48.8M $42.06M
$442.92M $368.19M $228.26M $198.6M $187.51M $190.2M $173.61M $155.67M $140.07M $117.63M $93.13M $65.98M $51.37M $41.24M $35.05M
— — — — — $0 $1.87M $2.9M $2.96M $2.73M $2.55M — — — —
— — — — — $192.35M $176.46M $160.5M $153.98M $130.25M $102.13M — — — —
— — — — — 100% 98.95% 98.23% 98.11% 97.94% 97.56% — — — —
$61.01M $52.47M $28.92M $21.81M $20.17M $26.87M $16.3M $15.16M $12.56M $11.12M $9.3M $7.66M $11.11M $5.44M $1.79M
$113.63M $92.89M $56.83M $51.2M $50.32M $55.39M $52.82M $51.87M $45.78M $39.18M $31.98M $24.13M $23M $23.42M $21.1M
$2.48M $2.48M $42.23M $36.3M $79.06M $0 — — — — — — — — —
$118.52M — — — — — — — $101.07M $110.65M $75.06M $64.92M $67.04M $49.07M $41.83M
$253.4M $206.46M $178.07M $159.78M $192.77M $109.47M $97.43M $118.82M $101.07M $110.65M — — — — —
$50.57M $43.71M $30.31M $40.88M $30.01M $23.68M $23.66M $28.13M $27.86M $24.2M $22.87M $24.05M $21.62M $12.65M $12.21M
$638K — — — — — — — — — $737K $945K $32K $0 —
— $4.35M $0 $0 — — — — — — — — — — —
$363.71M $325.29M $124.4M $53.72M — — — — — — — $10.03M -$8.14M -$272K $232K
$8.78M $5M $0 $0 — — — — — — — $0 $0 $123K $122K
$355.4M $320.54M $125.08M $53.74M -$7.51M $71.98M $80.87M $46.36M $57.92M $25.87M $29.35M $10.03M -$8.14M -$395K $110K
— 67.28% 42.22% 24.68% -3.83% 37.42% 45.35% 28.37% 36.91% 19.46% 28.04% 13.39% -13.83% -0.81% 0.26%
-$465K -$252K -$681K -$13K $0 $0 — — — — — — — — —
$354.83M $319.8M $124.64M $53.34M -$7.95M $71.48M $80.57M $46.06M — — — — — — —
$332.37M $326.41M $125.08M $53.74M — — — — — — $29.35M $10.03M -$6.32M $643K -$613K
USD/shares $1.60 $1.57 $0.81 $0.50 -$0.08 $0.74 $0.85 $0.49 $0.73 $0.35 $0.52 $0.26 -$0.36 -$0.02 $0.00
USD/shares $1.61 $1.57G $0.80 $0.50 -$0.08 $0.74 $0.85 $0.49 $0.72 $0.35 $0.52 $0.26 -$0.36 -$0.02 $0.00
shares — 203.64M 154.8M 105.96M 96.7M 96.02M 95.2M 93.09M 79.39M 72.65M 56.03M 37.38M 22.79M 22.23M 22.23M
shares — 204.09M 155.17M 106.15M 96.7M 96.09M 95.21M 93.1M 79.39M 72.65M 56.03M 37.38M 22.79M 22.23M 22.44M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2025: $1.14B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2026-06-30 USD 1,205,071,000 10-Q filed 2026-08-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Line of credit borrowings, including current maturities
USD 310,000,000
Noncurrent loans payable
USD 496,811,000
Notes payable, including current maturities
USD 398,260,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
17.10×
Peer median 8.81×
EV/EBIT
—
P/E (TTM)
22.64×
Peer median 53.60×
P/FFO (TTM)
23.19×
Peer median 20.60×

Peer medians compare against the 11 similar-size REIT - Healthcare Facilities companies (of 17 listed).

P/FFO uses the company-stated “Funds from Operations (FFO) attributable to CareTrust REIT, Inc.”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

P/FFO uses the company-stated “Funds from Operations (FFO) attributable to CareTrust REIT, Inc.”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Reportable Segment $476,393,000 $296,286,000 $217,770,000 $196,132,000
Key facts CIK 1590717 CUSIP 14174T107 13F (30d) 60 filings 60 filers Visit website Investor relations